Gardoni, Fabrizio
University of Milan
9 papers on CoChatORCID 0000-0003-4598-5563
Most cited papers
- Verified
Interleukin-1β Enhances NMDA Receptor-Mediated Intracellular Calcium Increase through Activation of the Src Family of Kinases
Viviani, B., Bartesaghi, S., Gardoni, F., Vezzani, A., Behrens, M. M., Bartfai, T., Binaglia, M., Corsini, E., Di Luca, M., Galli, C. L., et al. (2003) · The Journal of Neuroscience
Neuroscience and Neuropharmacology ResearchNeuroinflammation and Neurodegeneration Mechanisms
Cited by 893
- Verified
Neonatal exposure to brominated flame retardant BDE-47 reduces long-term potentiation and postsynaptic protein levels in mouse hippocampus
Dingemans, M. M. L., Ramakers, G. M. J., Gardoni, F., van Kleef, R. G. D. M., Bergman, Å., Di Luca, M., van den Berg, M., Westerink, R. H. S., & Vijverberg, H. P. M. (2007) · Environmental Health Perspectives
Toxic Organic Pollutants ImpactNeuroscience and Neuropharmacology Research
Cited by 133
- Verified
Elongation factor-2 phosphorylation in dendrites and the regulation of dendritic mRNA translation in neurons
Heise, C., Gardoni, F., Culotta, L., di Luca, M., Verpelli, C., & Sala, C. (2014) · Frontiers in Cellular Neuroscience
Neuroscience and Neuropharmacology ResearchRNA and protein synthesis mechanisms
Cited by 99
- Verified
Calcium–calmodulin‐dependent protein kinase II phosphorylation modulates PSD‐95 binding to NMDA receptors
Gardoni, F., Polli, F., Cattabeni, F., & Di Luca, M. (2006) · European Journal of Neuroscience
Neuroscience and Neuropharmacology ResearchProtein Kinase Regulation and GTPase Signaling
Cited by 90
- Verified
Toward a glutamate hypothesis of frontotemporal dementia
Benussi, A., Alberici, A., Buratti, E., Ghidoni, R., Gardoni, F., Di Luca, M., Padovani, A., & Borroni, B. (2019) · Frontiers in Neuroscience
Alzheimer's disease research and treatmentsAmyotrophic Lateral Sclerosis Research
Cited by 90
- Verified
Rebalance of Striatal NMDA/AMPA Receptor Ratio Underlies the Reduced Emergence of Dyskinesia During D2-Like Dopamine Agonist Treatment in Experimental Parkinson's Disease
Bagetta, V., Sgobio, C., Pendolino, V., Del Papa, G., Tozzi, A., Ghiglieri, V., Giampà, C., Zianni, E., Gardoni, F., Calabresi, P., et al. (2012) · The Journal of Neuroscience
Parkinson's Disease Mechanisms and TreatmentsDeep Brain Stimulation and Movement Disorders
Cited by 74
- Verified
SNAP-25 regulates spine formation through postsynaptic binding to p140Cap
Tomasoni, R., Repetto, D., Morini, R., Elia, C., Gardoni, F., Di Luca, M., Turco, E., Defilippi, P., & Matteoli, M. (2013) · Nature Communications
Neuroscience and Neuropharmacology ResearchCellular transport and secretion
Cited by 71
- Verified
Cyclase-associated protein 2 dimerization regulates cofilin in synaptic plasticity and Alzheimer's disease
Pelucchi, S., Vandermeulen, L., Pizzamiglio, L., Aksan, B., Yan, J., Konietzny, A., Bonomi, E., Borroni, B., Padovani, A., Rust, M. B., et al. (2020) · Brain Communications
Neuroscience and Neuropharmacology ResearchAlzheimer's disease research and treatments
Cited by 55
- Verified
Neuronal PCSK9 regulates cognitive performances via the modulation of ApoER2 synaptic localization
Pelucchi, S., Da Dalt, L., De Cesare, G., Stringhi, R., D’Andrea, L., La Greca, F., Cambria, C., Vandermeulen, L., Zianni, E., Musardo, S., et al. (2025) · Pharmacological Research
Neuroscience and Neuropharmacology ResearchAlzheimer's disease research and treatments
Cited by 12
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free